Abbott Receives FDA Authorization For Dual Glucose-Ketone Sensing Technology
Product·2 articles across 2 outlets·◆ Primary source
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
Abbott has received FDA authorization for its first-of-its-kind bio-wearable sensor designed for diabetics. This innovative technology can warn users of increased ketones that may lead to diabetic ketoacidosis.
The dual glucose-ketone sensing technology represents a significant advancement in diabetes management, providing real-time monitoring to help prevent serious health complications.
Abbott
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes”
SEC Filing — Abbott receives FDA authorization for world's first dual glucose-ketone sensing technology for people with diabetes“The FDA has approved Abbott’s first-of-its-kind bio-wearable sensor that can warn diabetics of increased ketones that can lead to diabetic ketoacidosis.”
fierce biotech — <a href="/medtech/fda-green-lights-abbotts-wearable-sensor-capturing-diabetic-ketoacidosis" hreflang="en">FDA greenlights Abbott’s wearable sensor for capturing diabetic ketoacidosis</a>